You are here

  • Home
  • Archive
  • Volume 31, Issue 8
  • Neoadjuvant chemoteraphy in unresectable ovarian cancer with olaparib and weekly carboplatin plus paclitaxel: a phase II, open label multicenter study (NUVOLA trial)

Article metrics

Article menu
Download PDFPDF
Clinical trial
Neoadjuvant chemoteraphy in unresectable ovarian cancer with olaparib and weekly carboplatin plus paclitaxel: a phase II, open label multicenter study (NUVOLA trial)

 

Online download statistics by month:

Online download statistics by month: June 2021 to April 2024

AbstractFullPdf
Jun 2021523514
Jul 202140149
Aug 2021382815
Sep 2021201610
Oct 202114299
Nov 202122273
Dec 20211091310
Jan 2022171114
Feb 202216584
Mar 2022165117
Apr 202216992
May 202215021
Jun 2022257113
Jul 202219281
Aug 202216394
Sep 202223491
Oct 202215441
Nov 202213572
Dec 20229452
Jan 20238461
Feb 202310642
Mar 20235750
Apr 20235363
May 20239284
Jun 20238254
Jul 20237443
Aug 20236255
Sep 20237032
Oct 202315386
Nov 202320660
Dec 20237263
Jan 20247153
Feb 20248941
Mar 20245653
Apr 20249723
Total4096298145